On the latest Talk Ya Book, Chris Judd welcomes back Andrew Chapman from Merchant Funds Management. Andrew talks us through bio-tech company Inoviq (ASX:IIQ), whose goal is to develop and commercialise a portfolio of diagnostic and exosome-based products for the earlier detection, diagnosis, prognosis and monitoring of cancer and other diseases. Merchant Funds Management specialise in small and micro-cap companies listed on the ASX. Proudly presented by Honan (www.honan.com.au).    See omnystudio.com/listener for privacy information.

Ver todos los episodios